VIA Pharmaceuticals, Inc.
VIAP
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | 41.83% | 73.65% | 52.35% | 32.13% | -0.47% |
| Total Depreciation and Amortization | -74.31% | -58.77% | -40.75% | -8.60% | -59.18% |
| Total Amortization of Deferred Charges | -5.50% | -92.38% | -81.87% | -89.57% | -- |
| Total Other Non-Cash Items | -117.17% | -46.89% | -19.25% | 42.85% | 4.20% |
| Change in Net Operating Assets | -32.17% | -14.91% | 234.05% | -622.75% | 5.93% |
| Cash from Operations | 50.29% | 55.51% | 72.67% | 20.56% | 29.94% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -71.25% | -85.00% | -37.50% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 333.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -71.25% | -84.97% | -37.59% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.93% | -92.86% | -160.99% | 0.69% | 30.13% |